Femme Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The purpose of this trial is to determine whether BIBF 1120 can be safely combined with pegylated liposomal doxorubicin (phase I), and to determine the clinical activity of the combination in patients with platinum-resistant ovarian cancer (phase II).
Critère d'inclusion
- Ovarian Cancer